These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6446429)

  • 21. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
    Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Education of lymphocytes in vivo following a transient take of a matched unrelated bone-marrow graft in man.
    Goldmann SF; Kristensen T; Grunnet N; Lohrmann HP; Heimpel H; Kissmeyer-Nielsen F
    Clin Exp Immunol; 1977 Aug; 29(2):266-71. PubMed ID: 143356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukaemia-associated antigens expressed by acute myelocytic leukaemia cells and their detection by heterologous antisera.
    Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):311-20. PubMed ID: 89982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
    Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
    Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of human lymphocytes reactive with autologous leukemia cells.
    Csako G; Binder RA; Kales AN; Neefe JR
    Cancer Res; 1980 Sep; 40(9):3218-21. PubMed ID: 6159073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Foetal antigens on leukaemia cells (author's transl)].
    Thränhardt H; Zintl F; Milleck J; Plenert W
    Arch Geschwulstforsch; 1978; 48(8):750-5. PubMed ID: 288321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
    Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
    Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Report of two cases of acute myelogenous leukemia immunized with autologous leukemia-derived hybrid cells.
    Cohen EP; Lazda VA; Schade SG; Kennedy JL; Kaufman ER; Hagen KL
    Mol Biother; 1988; 1(2):86-95. PubMed ID: 3269252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
    Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
    Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study.
    Montagna D; Locatelli F; Calcaterra V; Comoli P; Moretta A; Giorgiani G; Zecca M; Bonetti F; Giraldi E; Rondini G; Maccario R
    Bone Marrow Transplant; 1998 Oct; 22(8):743-50. PubMed ID: 9827970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.